Genomind Personalized Medicine Analysis
Scientists have discovered specific genetic variations that modify the body’s response to certain drugs and therapies. By identifying these variations, clinicians can design a treatment plan optimized for an individual patient. This new development is known as “personalized medicine.”
Personalized medicine has the potential to both increase treatment effectiveness and lower costs across a wide range of medical specialties. Applying this technology to mental health provides a more rational and personalized approach to treatment.
The Genecept Assay is a comprehensive, simple to use tool for understanding genetic and biological markers that best inform responses to different psychiatric treatments.
The Assay is Genomind’s core product. It consists of a proprietary panel of 10 biomarkers, an analytic report, and consultation with a psychopharmacologist.
The Assay’s purpose is to help clinicians more quickly find appropriate, effective treatment based on individual patients’ physiological and genetic profile. It can be used for patients with a range of difficult to treat psychiatric conditions including depression, bipolar disorder, schizophrenia, anxiety disorders, OCD and ADHD.
Resources
